Leuprorelin

ATC L02AE02 · 7 markets · 64 records

Leuprorelin 7 markets · 64 records Forms

GB 30 records · 9 strengths

AU 11 records · 6 strengths

  • 30 mginjection · extended-releaseEligard 4 monthLucrin Depot 4 Month PDS、Lucrin Depot Paediatric 30 mg PDS
  • 22.5 mginjection · extended-releaseEligard 3 monthLucrin Depot 3 Month PDS also in ES
  • 45 mginjection · extended-releaseEligard 6 monthLucrin Depot 6-Month
  • 7.5 mginjection · extended-releaseEligard 1 monthLucrin Depot 7.5mg PDS
  • 22.5 mgtablet · extended-releaseBi ELIGARD CP
  • 7.5 mgtablet · extended-releaseBi ELIGARD CP

ES 8 records · 7 strengths

CN 6 records · 4 strengths

  • 3.75 mginjection抑那通亮丙瑞林__mah__:TakedaPharmaceuticalCompany Limited、__mah__:上海丽珠制药有限公司 also in GB
  • 11.25 mginjectionManufacturer: TakedaPharmaceuticalCompany… ×2 also in GB
  • 3.75 mginjection · extended-releaseManufacturer: 北京博恩特药业有限公司 also in GB·ES
  • 1.88 mginjection抑那通亮丙瑞林

SG 1 records · 1 strengths

  • 42 mg/syringeinjection · extended-releaseCAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 CAMCEVI

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.